|
Side Effects & Drug Interactions
ADVERSE REACTIONS
Clinical studies comparing Humalog with human regular insulin did not demonstrate a difference in frequency of adverse events between the two treatments. Adverse events commonly associated with human insulin therapy include the following: Body as a Whole--allergic reactions (see related PRECAUTIONS information below) Text Continues Below
Skin and Appendages--injection site reaction, lipodystrophy, pruritus, rash Other--hypoglycemia (see related WARNINGS information below) 
Drug Interactions--( see CLINICAL PHARMACOLOGY)
Insulin requirements may be increased by medications with hyperglycemic activity such as corticcosteroids, isoniazid, certain lipid-lowering drugs (e. g., niacin), estrogens, oral contraceptives, phenothiazines, and thyroid replacement therapy. Insulin requirements may be decreased in the presence of drugs with hypoglycemic activity, such as oral hypoglycemic agents, salicylates, sulfa antibiotics, and certain antidepressants (monoamine oxidase inhibitors), certain angiotensin-converting-enzyme inhibitors, beta-adrenergic blockers, inhibitors of pancreatic function (e. g., octreotide), and alcohol. Beta-adrenergic blockers may mask the symptoms of hypoglycemia in some patients. Mixing of Insulins Care should be taken when mixing all insulins as a change in peak action may occur. The American Diabetes Association warns in its Position Statement on Insulin Administration, "On mixing, physiochemical changes in the mixture may occur (either immediately or over time). As a result, the physiological response to the insulin mixture may differ from that of the injection of the insulins separately." Mixing Humalog with Humulin N or Humulin U does not decrease the absorption rate or the total bioavailability of Humalog. Given alone or mixed with Humulin N, Humalog results in a more rapid absorption and glucose-lowering effect compared with human regular insulin. Page: 1 | 2 | Next >>
|
.gif)
